Blog article by John A. Hovanesian, MD, FACS
April 18, 2022
Dr. Hovanesian reported on his experience implanting the first AccuraSee™ intraocular pseudophakic contact lens to improve near vision in patients with macular degeneration.
“This is a fascinating invention from Kevin J. Cady, an eye care industry veteran who devised a small implant that rests on top of and couples with an existing posterior chamber IOL, altering its focus. The concept is loaded with promise.”
“The AccuraSee™ intraocular pseudophakic contact lens (IOPCL, OnPoint Vision) is part of a first-in-human investigational device exemption study. “
“The IOPCL’s possible uses, though, are what make it exciting because they go well beyond dry AMD. Future iterations of this IOL could incorporate lower power sphere cylinder to correct residual refractive error.”
“Other designs could address higher-order aberrations or perhaps unwanted visual side effects from multifocal lenses as well as a multifocal platform that is fully reversible.
“Best of all, early evaluation of the patients shows no measurable loss of best corrected distance visual acuity and a significant improvement in near, as is common when a high add is placed in these patients.”